Results 151 to 160 of about 286,030 (326)
Non-invasive EEG-based brain-computer interfaces in patients with disorders of consciousness [PDF]
Emilia Mikołajewska +1 more
openalex +1 more source
RAB39B Related Parkinsonism in an Italian Family: A Unique Use of Advanced Therapies
ABSTRACT Parkinson's disease (PD) is a neurodegenerative disorder that may sometimes be caused by deleterious genetic variants. Among them, RAB39B polymorphisms are known as rare causes of early‐onset PD associated with intellectual disability (Waisman's syndrome).
Caterina Del Regno +13 more
wiley +1 more source
This article explores the ethical and legal implications of enrolling individuals with disorders of consciousness (DOC) in neuroimaging research studies.
Tovino, Stacey A.
core
Can cranioplasty be effective in improving cognitive and motor function in patients with chronic disorders of consciousness? a case report [PDF]
Francesco Corallo +3 more
openalex +1 more source
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
Objectified body consciousness in relation to recovery from an eating disorder
Ellen E. Fitzsimmons‐Craft +2 more
openalex +2 more sources
As many patients with inflammatory arthritis (IA) have chronic pain, understanding how to best assess and manage pain in IA is a priority. Comorbid depression is prevalent in adults with IA, affecting 15% to 39% of people. Although pain and depression are thought to be associated in IA, this concept is largely based on cross‐sectional data.
Natasha Cox +3 more
wiley +1 more source
Disorders of consciousness: What's in a name?
Olivia Gosseries +6 more
openalex +2 more sources
Brain stimulation in patients with disorders of consciousness [PDF]
Aurore Thibaut, Steven Laureys
openalex +1 more source
Objective Cognitive impairment (CI) is common in patients with systemic lupus erythematosus (SLE). Despite its prevalence, the immune mechanisms are not well understood. We previously reported elevated serum levels of S100A8/A9 and matrix metalloproteinase 9 (MMP‐9) in patients with SLE and CI.
Carolina Muñoz‐Grajales +18 more
wiley +1 more source

